GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » Cyclically Adjusted PS Ratio

Teva Pharmaceutical Industries (MEX:TEVA N) Cyclically Adjusted PS Ratio : 0.82 (As of Jul. 06, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio?

As of today (2025-07-06), Teva Pharmaceutical Industries's current share price is MXN315.30. Teva Pharmaceutical Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was MXN383.35. Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio for today is 0.82.

The historical rank and industry rank for Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:TEVA N' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.29   Med: 0.68   Max: 4.32
Current: 0.83

During the past years, Teva Pharmaceutical Industries's highest Cyclically Adjusted PS Ratio was 4.32. The lowest was 0.29. And the median was 0.68.

MEX:TEVA N's Cyclically Adjusted PS Ratio is ranked better than
77.34% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.18 vs MEX:TEVA N: 0.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted revenue per share data for the three months ended in Mar. 2025 was MXN68.682. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN383.35 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.35 0.43 0.52 1.16

Teva Pharmaceutical Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.85 0.93 1.16 0.81

Competitive Comparison of Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio falls into.


;
;

Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=315.30/383.35
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Teva Pharmaceutical Industries's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=68.682/134.9266*134.9266
=68.682

Current CPI (Mar. 2025) = 134.9266.

Teva Pharmaceutical Industries Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 90.707 100.684 121.557
201509 94.546 100.392 127.070
201512 95.809 99.792 129.541
201603 89.999 100.470 120.864
201606 101.272 101.688 134.374
201609 109.312 101.861 144.796
201612 131.479 101.863 174.156
201703 104.606 102.862 137.214
201706 101.666 103.349 132.729
201709 100.233 104.136 129.870
201712 94.061 104.011 122.019
201803 90.215 105.290 115.609
201806 90.739 106.317 115.157
201809 83.217 106.507 105.422
201812 75.795 105.998 96.481
201903 73.801 107.251 92.845
201906 73.458 108.070 91.714
201909 73.996 108.329 92.164
201912 77.221 108.420 96.100
202003 93.214 108.902 115.490
202006 81.207 108.767 100.738
202009 80.181 109.815 98.516
202012 80.876 109.897 99.296
202103 73.529 111.754 88.775
202106 70.183 114.631 82.609
202109 72.050 115.734 83.998
202112 76.323 117.630 87.546
202203 65.848 121.301 73.245
202206 68.601 125.017 74.039
202209 64.623 125.227 69.629
202212 68.017 125.222 73.288
202303 59.200 127.348 62.723
202306 59.345 128.729 62.202
202309 59.086 129.860 61.392
202312 67.609 129.419 70.486
202403 56.439 131.776 57.788
202406 67.330 132.554 68.535
202409 75.268 133.029 76.342
202412 77.777 133.157 78.811
202503 68.682 134.927 68.682

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Teva Pharmaceutical Industries  (MEX:TEVA N) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines